IL10 and lung cancer: In line with the finding that glufosinate hinders M2‐like features, A549 human lung cancer cells in the presence of glufosinate/IL10 macrophages were significantly less motile in a concentration‐dependent fashion in comparison to cells exposed to IL10‐stimulated control macrophages (Figs 2Q and EV1C).